Stocks

Corient Private Wealth LP Invests $187 Million in Amgen

Guavy AI Editorial Team Published August 27, 2026

Instruments

AMGN

Corient Private Wealth LP has made a significant investment in Amgen Inc. (NASDAQ:AMGN), purchasing approximately $187.40 million worth of shares, according to its most recent 13F filing with the Securities & Exchange Commission.

The firm acquired 1,041,051 shares of Amgen's stock, representing about 0.19% of the company's total ownership at the end of the second quarter.

This investment is just one example of the significant interest that institutional investors have shown in Amgen lately. Other large investors, such as Roman Butler Fullerton & Co., High Note Wealth LLC, TAGStone Capital Inc., and Verus Capital Partners LLC, have also increased their holdings in the company during the same period.

Amgen's stock has been performing well recently, with shares opening at $440.34 on Thursday. The company has a market capitalization of approximately $238 billion and a P/E ratio of 27.37.

Corient Private Wealth LP Invests $187 Million in Amgen

Salesforce Prepares for AI-Driven Future with Outcome-Based Pricing

CPPIB Invests Heavily in Travelers Companies Amid Strong Earnings

CDPQ Invests Heavily in The Travelers Companies, Inc.